Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 06 06 2019
accepted: 17 07 2019
pubmed: 11 8 2019
medline: 16 5 2020
entrez: 11 8 2019
Statut: ppublish

Résumé

The complement system, a part of the innate immune system, can be activated via three different pathways. In the alternative pathway, a factor D (FD) plays essential roles in both the initiation and the amplification loop and circulates as an active form. Mannose-binding lectin-associated serine proteases (MASPs) are key enzymes of the lectin pathway, and MASP-1 and/or MASP-3 are reported to be involved in the activation of FD. In the current study, we generated mice monospecifically deficient for MASP-1 or MASP-3 and found that the sera of the MASP-1-deficient mice lacked lectin pathway activity, but those of the MASP-3-deficient mice lacked alternative pathway activity with a zymogen FD. Furthermore, the results indicate that MASP-3 but not MASP-1 activates the zymogen FD under physiological conditions and MASP-3 circulates predominantly as an active form. Therefore, our study illustrates that, in mice, MASP-3 orchestrates the overall complement reaction through the activation of FD.

Identifiants

pubmed: 31399515
pii: jimmunol.1900605
doi: 10.4049/jimmunol.1900605
doi:

Substances chimiques

Lectins 0
Complement System Proteins 9007-36-7
MASP-3 protein, mouse EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases EC 3.4.21.-
Complement Factor D EC 3.4.21.46

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1411-1416

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 by The American Association of Immunologists, Inc.

Auteurs

Manabu Hayashi (M)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Takeshi Machida (T)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan; be204093@fmu.ac.jp.

Yumi Ishida (Y)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Yusuke Ogata (Y)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Tomoko Omori (T)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Mika Takasumi (M)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.
Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Yuichi Endo (Y)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Toshiyuki Suzuki (T)

Radioisotope Research Center, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Masayuki Sekimata (M)

Radioisotope Research Center, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Yoshimi Homma (Y)

Department of Biomolecular Science, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Masahito Ikawa (M)

Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan; and.

Hiromasa Ohira (H)

Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Teizo Fujita (T)

Fukushima Prefectural General Hygiene Institute, Fukushima City, Fukushima 960-8141, Japan.

Hideharu Sekine (H)

Department of Immunology, Fukushima Medical University School of Medicine, Fukushima City, Fukushima 960-1295, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH